发明名称 |
ADMINISTRATION OF NEDD8-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS |
摘要 |
Disclosed are methods for the treatment of various solid tumors in patients in need of such treatment. The methods comprise administering to such a patient an NEDD8-activating enzyme (NAE) inhibitor such as (1S,2S,4R)-4-4-(1S)-2,3-dihydro 1H-inden-1-ylamino)-7H-pyrrolo[2,3-d]-pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate (MLN4924) or a pharmaceutically acceptable salt in combination with one or more chemotherapeutic agents. Also disclosed are medicaments for use in the treatment of various solid tumors. |
申请公布号 |
US2016074404(A1) |
申请公布日期 |
2016.03.17 |
申请号 |
US201414889571 |
申请日期 |
2014.05.13 |
申请人 |
MILLENNIUM PHARMACEUTCALS, INC. |
发明人 |
BERGER Allison;LIGHTCAP Eric S. |
分类号 |
A61K31/519;A61K33/24;A61K31/7068;A61K31/555;A61K45/06;A61K31/337 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a solid tumor, comprising administering to a patient in need of such treatment a combination of ((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate or a pharmaceutically acceptable salt thereof, and one or more of:
i) a platin ii) a taxane; or iii) gemcitabine. |
地址 |
Cambridge MA US |